Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells

Ameres, S.L., Zamore, P.D., 2013. Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol., 14(8):475–488. http://dx.doi.org/10.1038/nrm3611

Baron, V.T., Pio, R., Jia, Z., et al., 2015. Early growth response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer. Br. J. Cancer, 112(4):755–764. http://dx.doi.org/10.1038/bjc.2014.622

Bartel, D.P., 2009. MicroRNAs: target recognition and regulatory functions. Cell, 136(2):215–233. http://dx.doi.org/10.1016/j.cell.2009.01.002

Bronte, F., Bronte, G., Fanale, D., et al., 2015. Hepatomirnoma:the proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma. Crit. Rev. Oncol. Hematol., 97:312–321. http://dx.doi.org/10.1016/j.critrevonc.2015.09.007

Fang, F., Shangguan, A.J., Kelly, K., et al., 2013. Early growth response 3 (Egr-3) is induced by transforming growth factor-β and regulates fibrogenic responses. Am. J. Pathol., 183(4):1197–1208. http://dx.doi.org/10.1016/j.ajpath.2013.06.016

Farazi, T.A., Juranek, S.A., Tuschl, T., 2008. The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members. Development, 135(7):1201–1214. http://dx.doi.org/10.1242/dev.005629

Felekkis, K., Touvana, E., Stefanou, C., et al., 2010. MicroRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia, 14(4):236–240.

Fong, Z.V., Tanabe, K.K., 2014. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer, 120(18):2824–2838. http://dx.doi.org/10.1002/cncr.28730

Gomez-Martin, D., Diaz-Zamudio, M., Galindo-Campos, M., et al., 2010. Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. Autoimmun. Rev., 9(6):454–458. http://dx.doi.org/10.1016/j.autrev.2009.12.006

Hu, X., Schwarz, J.K., Lewis, J.S., et al., 2010. A microRNA expression signature for cervical cancer prognosi, Cancer Res., 70(4):1441–1448. http://dx.doi.org/10.1158/0008-5472.can-09-3289

Kimhofer, T., Fye, H., Taylor-Robinson, S., et al., 2015. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br. J. Cancer, 112(7):1141–1156. http://dx.doi.org/10.1038/bjc.2015.38

Leng, R., Zha, L., Tang, L., 2014. MiR-718 represses VEGF and inhibits ovarian cancer cell progression. FEBS Lett., 588(12):2078–2086. http://dx.doi.org/10.1016/j.febslet.2014.04.040

Li, L., Yun, S.H., Keblesh, J., et al., 2007. Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. Mol. Cell. Neurosci., 35(1):76–88. http://dx.doi.org/10.1016/j.mcn.2007.02.004

Liao, F., Ji, M.Y., Shen, L., et al., 2013. Decreased Egr3 expression is related to poor prognosis in patients with gastric cancer. J. Mol. Histol., 44(4):463–468. http://dx.doi.org/10.1007/s10735-013-9493-8

Lin, M., Chen, W., Huang, J., et al., 2011. MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol. Rep., 25(3):739–747. http://dx.doi.org/10.3892/or.2010.1112

Perez-Cadahia, B., Drobic, B., Davie, J.R., 2011. Activation and function of immediate-early genes in the nervous system. Biochem. Cell Biol., 89(1):61–73. http://dx.doi.org/10.1139/o10-138

Pio, R., Jia, Z., Baron, V.T., et al., 2013. Early growth response 3 (Egr3) is highly over-expressed in nonrelapsing prostate cancer but not in relapsing prostate cancer. PLoS ONE, 8(1):e54096. http://dx.doi.org/10.1371/journal.pone.0054096

Shukla, G.C., Singh, J., Barik, S., 2011. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol., 3(3):83–92.

Singh, R., Yadav, V., Kumar, S., et al., 2015. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1. Sci. Rep., 5:17454. http://dx.doi.org/10.1038/srep17454

Sugimachi, K., Matsumura, T., Hirata, H., et al., 2015. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. Br. J. Cancer, 112(3):532–538. http://dx.doi.org/10.1038/bjc.2014.621

Suzuki, T., Inoue, A., Miki, Y., et al., 2007. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor. Endocr. Relat. Cancer, 14(2):279–292. http://dx.doi.org/10.1677/erc-06-0005

Waller, L.P., Deshpande, V., Pyrsopoulos, N., 2015. Hepatocellular carcinoma: a comprehensive review. World J. Hepatol., 7(26):2648–2663. http://dx.doi.org/10.4254/wjh.v7.i26.2648

Wan, H.Y., Li, Q.Q., Zhang, Y., et al., 2014. MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells. Cancer Lett., 355(1):148–158. http://dx.doi.org/10.1016/j.canlet.2014.09.005